Stockscreener 앱 받기
1.9817
1.27%
0.0217
전일 마감가:
$1.96
열려 있는:
$2
하루 거래량:
769.93K
Relative Volume:
0.67
시가총액:
$176.12M
수익:
$34.48M
순이익/손실:
$-102.07M
주가수익비율:
-1.0888
EPS:
-1.82
순현금흐름:
$-104.90M
1주 성능:
-5.03%
1개월 성능:
+0.75%
6개월 성능:
-35.77%
1년 성능:
-62.55%
1일 변동 폭
$1.91
$2.0389
1주일 범위
$1.91
$2.12
52주 변동 폭
$1.50
$8.33
Caribou Biosciences Inc Stock (CRBU) Company Profile
명칭
Caribou Biosciences Inc
전화
510-982-6030
주소
2929 7TH STREET, SUITE 105, BERKELEY
CRBU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| CRBU | 1.98 | 176.12M | 34.48M | -102.07M | -104.90M | -1.82 |
| VRTX | 449.39 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 747.14 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 595.48 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.50 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.12 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-11 | 개시 | Truist | Buy |
| 2022-02-18 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-30 | 개시 | H.C. Wainwright | Buy |
| 2021-11-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-08-17 | 개시 | BofA Securities | Buy |
| 2021-08-17 | 개시 | Citigroup | Neutral |
| 2021-08-17 | 개시 | SVB Leerink | Outperform |
모두보기
Caribou Biosciences Inc 주식(CRBU)의 최신 뉴스
Caribou Biosciences to Participate in Upcoming Investor Conferences - The Manila Times
Caribou Biosciences CEO to Present at Major Healthcare Conferences on CRISPR Advances | CRBU Stock News - StockTitan
The Rosen Law Firm, P.A. Announces Proposed Class Action - GlobeNewswire
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Caribou Biosciences, Inc. – CRBU - GlobeNewswire Inc.
Steven Cohen's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com
Caribou Biosciences (NASDAQ:CRBU) Receives Buy Rating from HC Wainwright - MarketBeat
PFM Health Sciences, LP Increases Stake in Caribou Biosciences I - GuruFocus.com
Caribou Biosciences' SWOT analysis: biotech stock's potential amid clinical trials - Investing.com Australia
Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Lags Revenue Estimates - MSN
Brokers Set Expectations for CRBU FY2024 Earnings - Defense World
Leerink Partnrs Issues Optimistic Forecast for CRBU Earnings - Defense World
What is Leerink Partnrs' Forecast for CRBU FY2024 Earnings? - MarketBeat
CRBU FY2024 EPS Increased by Brookline Capital Management - MarketBeat
Caribou Biosciences, Inc. (NASDAQ:CRBU) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance
Caribou Biosciences (NASDAQ:CRBU) Announces Quarterly Earnings Results - MarketBeat
Caribou Biosciences (NASDAQ:CRBU) vs. Sutro Biopharma (NASDAQ:STRO) Financial Analysis - Defense World
Caribou Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Caribou Biosciences earnings beat by $0.07, revenue fell short of estimates - Investing.com UK
Caribou Biosciences reports Q3 EPS (38c), consensus (45c) - TipRanks
Caribou Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update - StockTitan
CRISPR Technology Market Report 2024, with Profiles of Major Players Agilent Technologies, Beam Therapeutics, Caribou Biosciences, Crispr Therapeutics, Danaher, Genscript, Lonza and MoreResearchAndMarkets.com | FinancialContent Business Page - Financial Content
Caribou Biosciences, Inc.'s (NASDAQ:CRBU) Shares Bounce 25% But Its Business Still Trails The Industry - Simply Wall St
Vanguard Group Inc's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com
Critical Analysis: Caribou Biosciences (NASDAQ:CRBU) & Titan Pharmaceuticals (NASDAQ:TTNP) - Defense World
Is Caribou Biosciences (CRBU) a Promising Gene Editing Stock? - Insider Monkey
10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds - Insider Monkey
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Bought by Exchange Traded Concepts LLC - Defense World
STATE STREET CORP's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com
Following a 49% decline over last year, recent gains may please Caribou Biosciences, Inc. (NASDAQ:CRBU) institutional owners - Simply Wall St
Its Stock Has Paid Off Big Time For Caribou Biosciences Inc - SETE News
How to interpret Caribou Biosciences Inc (CRBU)’s stock chart patterns - US Post News
Daily Market Movement: Caribou Biosciences Inc (CRBU) Sees a 5.56 Increase, Closing at 1.90 - The Dwinnex
Dimensional Fund Advisors LP Has $4.30 Million Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - MarketBeat
A better buy-in window may exist right now for Caribou Biosciences Inc (CRBU) - SETE News
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Purchased by Green Alpha Advisors LLC - Defense World
Caribou Biosciences Inc (CRBU) presents a great opportunity, but the stock is slightly undervalued - US Post News
Analyzing Ratios: Caribou Biosciences Inc (CRBU)’s Financial Story Unveiled - The Dwinnex
Susquehanna Fundamental Investments LLC Sells 91,637 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Acquired by American Century Companies Inc. - Defense World
Point72 DIFC Ltd Purchases 23,995 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Point72 Asset Management L.P. Decreases Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - MarketBeat
Point72 Asset Management L.P. Sells 1,241,478 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
1,482,900 Shares in Caribou Biosciences, Inc. (NASDAQ:CRBU) Bought by Renaissance Technologies LLC - Defense World
31,831 Shares in Caribou Biosciences, Inc. (NASDAQ:CRBU) Purchased by Point72 Asia Singapore Pte. Ltd. - Defense World
Taking on analysts’ expectations and winning: Caribou Biosciences Inc (CRBU) - SETE News
Daily Market Movement: Caribou Biosciences Inc (CRBU) Sees a 2.06 Increase, Closing at 1.98 - The Dwinnex
Caribou Biosciences Inc (CRBU) presents a great opportunity, but the stock is slightly overvalued - US Post News
Caribou Biosciences: CB-010, chRDNA Technology Continue To Show Promise In Gene Editing - Seeking Alpha
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Acquired by Point72 DIFC Ltd - Defense World
Wall Street SWOT: Caribou Biosciences stockInnovative biotech with HLA-matching focus - Investing.com
CRISPR and CRISPR-Associated (Cas) Genes Market 2024 Business Standards and Competition Landscape 2032 – Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics – Cauverynews - Cauverynews
Caribou Biosciences Inc (CRBU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.80%
0.42%
자본화:
|
볼륨(24시간):